Lianluo Smart (LLIT) Stock Price, News & Analysis

Company Overview

Lianluo Smart Limited, together with its subsidiaries, designs, develops, markets, and distributes medical products primarily in China and internationally. The company offers medical devices, including wearable sleep respiratory solutions, general hospital products, medical compressors, and related supporting products. It also provides technical services in relation to the detection and analysis of obstructive sleep apnea syndrome to hospitals and medical centers through medical wearable devices. In addition, the company distributes medical products, such as sleep apnea machines. Lianluo Smart Limited sells its products primarily through distributors; and directly to hospitals, physical examination centers, and sleep centers, as well as to individual consumers. The company was formerly known as Dehaier Medical Systems Limited and changed its name to Lianluo Smart Limited in November 2016. Lianluo Smart Limited was incorporated in 2003 and is headquartered in Beijing, China.

Key Stats

• Today's Range: $0.60 to $0.63
• 50-Day Range: $6.04 to $13.24
• 52-Week Range: $2.76 to $17.14
• Volume: 388,606 shs
• Average Volume: 1.04 million shs
• Market Capitalization: $1.37 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LLIT Stock Analysis - Frequently Asked Questions

When did Lianluo Smart's stock split?

Lianluo Smart shares reverse split before market open on Monday, October 26th 2020. The 1-8 reverse split was announced on Friday, October 23rd 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 23rd 2020. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

What other stocks do shareholders of Lianluo Smart own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Lianluo Smart investors own include FuelCell Energy (FCEL), iBio (IBIO), Inovio Pharmaceuticals (INO), Pfizer (PFE), Tonix Pharmaceuticals (TNXP), Actinium Pharmaceuticals (ATNM) and Novavax (NVAX).

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & Medical Instruments
• Sub-Industry: N/A
• Current Symbol: NASDAQ:LLIT
• CUSIP: N/A
• CIK: 1474627
• Web: www.lianluosmart.com
• Phone: 86-10-8978-8107
• Fax: N/A
• Employees: 6
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.42
• Quick Ratio: 2.17

Sales & Book Value

• Annual Sales: $380,000.00
• Price / Sales: 3.60
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.59) per share
• Price / Book: -1.05

Miscellaneous

• Outstanding Shares: 2,211,000
• Free Float: N/A
• Market Cap: $1.37 million
• Optionable: Not Optionable
• Beta: 0.16